IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ODICINO, Franco Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.593
EU - Europa 5.175
AS - Asia 4.228
SA - Sud America 796
AF - Africa 126
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 18.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.396
IT - Italia 1.987
SG - Singapore 1.401
CN - Cina 1.304
BR - Brasile 674
UA - Ucraina 647
HK - Hong Kong 549
PL - Polonia 495
DE - Germania 482
GB - Regno Unito 318
FI - Finlandia 269
VN - Vietnam 208
TR - Turchia 203
RU - Federazione Russa 190
IN - India 151
CH - Svizzera 143
IE - Irlanda 142
CA - Canada 114
FR - Francia 104
ID - Indonesia 78
ES - Italia 70
BD - Bangladesh 65
SE - Svezia 63
AU - Australia 53
AR - Argentina 52
MX - Messico 52
NL - Olanda 51
JP - Giappone 50
EE - Estonia 49
ZA - Sudafrica 43
IQ - Iraq 36
SA - Arabia Saudita 31
AT - Austria 20
MY - Malesia 18
CZ - Repubblica Ceca 17
EC - Ecuador 17
LT - Lituania 17
PT - Portogallo 15
BE - Belgio 14
MA - Marocco 14
PE - Perù 14
PK - Pakistan 14
LI - Liechtenstein 13
CL - Cile 12
AE - Emirati Arabi Uniti 11
NZ - Nuova Zelanda 11
UZ - Uzbekistan 11
EG - Egitto 10
LU - Lussemburgo 10
PH - Filippine 10
AZ - Azerbaigian 9
BG - Bulgaria 9
CO - Colombia 9
DZ - Algeria 9
JO - Giordania 9
KE - Kenya 9
SK - Slovacchia (Repubblica Slovacca) 9
IL - Israele 8
JM - Giamaica 8
KZ - Kazakistan 7
MK - Macedonia 7
NP - Nepal 7
TN - Tunisia 7
VE - Venezuela 7
AL - Albania 6
DK - Danimarca 6
ET - Etiopia 6
IR - Iran 6
KR - Corea 6
BH - Bahrain 5
EU - Europa 5
GH - Ghana 5
GR - Grecia 5
KG - Kirghizistan 5
NG - Nigeria 5
LK - Sri Lanka 4
MU - Mauritius 4
OM - Oman 4
PY - Paraguay 4
TH - Thailandia 4
UG - Uganda 4
UY - Uruguay 4
BO - Bolivia 3
BS - Bahamas 3
CR - Costa Rica 3
HN - Honduras 3
IS - Islanda 3
PS - Palestinian Territory 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
CM - Camerun 2
GT - Guatemala 2
HR - Croazia 2
MG - Madagascar 2
MN - Mongolia 2
NO - Norvegia 2
SN - Senegal 2
Totale 18.964
Salva come PNG Salva come JPEG
Città #
Fairfield 913
Ashburn 836
Woodbridge 768
Singapore 626
Hong Kong 541
Houston 486
Warsaw 480
Jacksonville 443
Seattle 384
Wilmington 384
Chandler 344
Ann Arbor 338
Cambridge 322
Beijing 297
New York 284
Princeton 239
Los Angeles 212
Dearborn 168
Milan 168
Nanjing 158
Brescia 151
Dublin 141
Istanbul 140
Helsinki 136
Munich 127
Des Moines 100
London 94
Moscow 90
Dallas 89
Zurich 87
Chicago 83
Ho Chi Minh City 79
Rome 70
Redondo Beach 69
Buffalo 67
San Francisco 66
São Paulo 66
Shanghai 63
Boardman 57
The Dalles 55
Shenyang 51
Nanchang 49
Tallinn 49
Jakarta 47
Changsha 43
Hangzhou 42
Toronto 42
Hanoi 41
Hebei 40
San Diego 40
Tianjin 36
Turku 33
Jinan 32
Denver 31
Santa Clara 31
Stockholm 31
Tokyo 30
Chennai 29
Jiaxing 29
Frankfurt am Main 28
Guangzhou 28
Montreal 28
Johannesburg 27
Brooklyn 26
Poplar 26
Kunming 25
Nuremberg 23
Charlotte 22
Romola 22
Melbourne 21
Dong Ket 20
Lappeenranta 19
Washington 19
Belo Horizonte 18
Phoenix 18
Pune 18
Turin 18
Ankara 17
Boston 17
Dhaka 17
Paris 17
Pleasanton 16
Verona 16
Brasília 15
Hefei 15
Mexico City 15
Orange 15
Zhengzhou 15
Brussels 14
Atlanta 13
Baghdad 13
Dalmine 13
Lancaster 13
Rio de Janeiro 13
Amsterdam 12
Cedar Knolls 12
Haikou 12
Orem 12
Salvador 12
Manchester 11
Totale 11.678
Salva come PNG Salva come JPEG
Nome #
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 2.443
Preeclampsia and late fetal growth restriction 334
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 326
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 309
Claudin3 is localized outside the tight junctions in human carcinomas 272
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 264
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 202
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 196
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 187
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 183
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 174
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 170
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 166
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 165
Role of 18F-FDG PET/CT in restaging and follow-up of patients with uterine sarcomas 165
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum 162
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum 161
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 161
Consolidation therapies revisited: weekly paclitaxel 160
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 157
Carcinoma of the Fallopian tube 152
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 151
Clinical and prognostic value of 18 F-FDG PET/CT in recurrent endometrial carcinoma 150
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study 142
Carcinoma of the Fallopian tube 138
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 134
Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experience 133
Early stage ovarian cancer: the Italian contribution to clinical research. An update 133
Replacement therapy for breast cancer survivors. A pilot study 132
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers 132
null 132
Gestational trophoblastic diseases 131
Parametrial endometriosis with ureteral involvement: A case report of a conservative approach without ureteral resection 131
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 131
Carcinoma of the corpus uteri 129
Role of HPV DNA, HPV mRNA and cytology in the follow-up of women treated for cervical dysplasia. 129
Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study 128
Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium 127
History of the FIGO cancer staging system 126
Staging classification for cancer of the ovary, fallopian tube, and peritoneum 125
Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico-pathologic entity 124
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 124
Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 123
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 123
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 123
Carcinoma of the fallopian tube. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 122
Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. 122
Carcinoma of the corpus uteri 122
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 122
Hormone replacement therapy in breast cancer 122
Female Adnexal Tumor of Probable Wolffian Origin (FATWO): Case Report and Systematic Literature Review 121
New development of the FIGO staging system. 121
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 121
Systemic therapy for gynecological neoplasms: ovary, cervix and endometrium 120
Interval debulking surgery in advanced epithelial ovarian cancer 120
Gestational trophoblastic diseases 120
Ultrasound examination in ovarian cancer patients. A comparison with second look laparotomy 120
Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 119
Systemic therapy for gynecological neoplasms: ovary, cervix, and endometrium. 119
Optimizing gemcitabine regimens in ovarian cancer. 118
Five-year follow-up of placental involution after abdominal pregnancy 118
Revised FIGO staging for carcinoma of the cervix. 117
Uterine sarcomas: a clinicopathologic study 117
Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimens 117
Staging of gynecologic malignancies 117
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 116
Carcinoma of the vagina 115
Management of endometrial cancer in Italy: a national survey endorsed by the Italian Society of Gynecologic Oncology 115
Crossover study with cisplatin or carboplatin in advanced ovarian cancer 114
Carcinoma of the cervix uteri 114
Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship 113
Which second-line treatment regimen should be used following relapse of platinum-sensitive ovarian cancer? 112
Carcinoma of the ovary 111
Ovarial cancer: best timing and applications of debulking surgery 111
Carcinoma of the ovary 110
Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 108
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology. 106
Carcinoma of the vagina 106
High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy 105
Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP) 103
Carcinoma of the vulva 102
Cancer in women 102
Carcinoma of the cervix uteri 102
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 101
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 99
Delaying surgery for patients with a previous SARS-CoV-2 infection 97
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group) 96
Integrated mutational landscape analysis of uterine leiomyosarcomas 95
The treatment of progressive ovarian carcinoma with D-Trp-LHRH (Decapeptyl). Gruppo Oncologico Nord ovest (GONO) 93
Surgery of advanced malignant epithelial tumours of the ovary 91
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 91
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 90
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 88
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 87
Carcinoma of the vagina. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 87
Chorionicity, birth weight discordance and neonatal morbidity in uncomplicated twin pregnancies delivered from 36 weeks 84
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 83
Early non-compliance to ERAS in gynecological open surgery for malignancies, and post-operative complications: a multicenter, prospective, observational, cohort study 82
Gestational trophoblastic neoplasia. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 82
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study 82
Totale 15.548
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.270
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.066 0 0 0 0 0 169 67 188 159 271 136 76
2021/20221.018 64 157 6 43 3 51 105 70 48 122 96 253
2022/20232.139 159 59 207 274 229 283 67 148 193 128 211 181
2023/20242.370 177 106 201 159 209 375 137 183 361 245 45 172
2024/20253.546 42 113 96 471 307 310 324 143 392 252 657 439
2025/20263.580 683 832 447 826 728 64 0 0 0 0 0 0
Totale 19.463